The NAD+ 1000mg & Retatrutide: A UK Innovation in Cellular Health
Emerging research from the tirzepatide 40mg UK are generating considerable excitement surrounding the potential pairing of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This intriguing approach aims to address